1 / 6

Gene Therapy Market Focus to Boost Market with Massive Growth

The global gene therapy market was valued at $584 million in 2016, and is estimated to reach $4,402 million by 2023, registering a CAGR of 33.3% from 2017 to 2023.

newmarketindustry
Download Presentation

Gene Therapy Market Focus to Boost Market with Massive Growth

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Gene Therapy Market

  2. Rise in funding for R&D activities related to gene therapy, growing awareness of gene therapy, increased government support, rise in prevalence of cancer and the acceptance of gene therapy in its treatment drive the gene therapy market growth. The viral vector segment would dominate the market through 2023. The tumor suppressor segment would achieve the fastest growth during the study period. The oncological disorders segment would dominate the market through 2023. According to the report, the global gene therapy market garnered $784 million in 2017 and is expected to reach $4,402 million by 2023, registering a CAGR of 33.3% from 2017 to 2023. Get Sample Report

  3. The report provides a comprehensive analysis of the gene therapy market covering details on research methodology, market size and share, market dynamics, market classification, and company profiles. The report serves as a vital tool for stakeholders such as market players and investors as it helps them identify the opportunities in the field and provides them with accurate data that empowers smart decision making. The report offers an analysis of the market dynamics which include the growth drivers, restraints and opportunities. Increase in funding for R&D activities pertaining to gene therapy and increase in awareness regarding gene therapy drive the market. Nonetheless, high cost associated with the treatment and unwanted immune responses restrict the growth of the industry.

  4. The report offers a broad segmentation of the global gene therapy market. It segments the market into vector type, gene type, applications, and geography. Based on vector type, it is classified into viral vector and non-viral vector. The viral vector segment captured more than half of the market share in 2017 and is likely to remain dominant during the forecast period. The gene type segment is bifurcated into antigen, cytokine, tumor suppressor, suicide, deficiency, growth factors, receptors, and others. The tumor suppressor segment is expected to grow at the fastest CAGR of 35.5% during the study period.

  5. KEY FINDINGS OF GENE THERAPY MARKET STUDY • Non-viral vectors is projected to grow at the highest rate during the analysis period. • Oncological disorders segment generated the highest revenue, and is expected to continue its dominance in future. • North America dominated global gene therapy market in 2016, and is projected to continue its dominance in future. • China is expected to grow highest in the Asia-Pacific region during the forecast period. • Antigen was the largest contributor among the gene type segments.

  6. The key companies profiled in the report include Novartis, Kite Pharma, Inc., GlaxoSmithKline PLC, Spark Therapeutics Inc., Bluebird bio Inc., Genethon, Transgene SA, Applied Genetic Technologies Corporation, Oxford BioMedica, and NewLink Genetics Corp. Other prominent players in the value chain include Amgen, Epeius Biotechnologies, Abeona Therapeutics, Sanofi, UniQure, Juno Therapeutics, Adaptimmune, Celgene, and Advantagene.

More Related